Hospira Recent News
#PreMarket Primer: Monday, July 28: Tension Between U.S. And Israel On The Rise
Market Wrap For April 1: S&P 500 Hitting New All-Time High Not An April Fools' Joke
Top Trending Tickers On StockTwits For February 12
Barron's Recap (2/9/12): Best Fund Families
Caterpillar, Discover Financial and Other Illinois Primary Stock Picks
Goldman Sachs Maintains Neutral on Hospira
Citi Maintains Sell Rating on Hospira
Morgan Stanley Reiterates Equal-Weight on Hospira
J.P. Morgan Maintains OW Rating on Hospira Following Management Meeting
Goldman Sachs Downgrades HSP To Neutral
UPDATE: J.P. Morgan Color On HSP Target Increase
JP Morgan Raises PT On Hospira To $66
Citigroup Downgrades Hospira To Sell, PT to $54
HSP's 1Q11 IMS Sales Are Improving, Morgan Stanley Reports
Morgan Stanley Increases HSP 1Q11 Estimates
Goldman Sachs Maintains Buy Rating On Hospira
Citigroup Upgrades Hospira To Hold, PT To $52
Goldman Sachs Lowers PT on Hospira to $59 (HSP)